It takes a village: Celebrating community in infectious disease research
At EPI Research Day 2025, Alberto Paniz-Mondolfi underscores the need for collaboration in infectious disease research.
At EPI Research Day 2025, Alberto Paniz-Mondolfi underscores the need for collaboration in infectious disease research.
The University of Florida Emerging Pathogens Institute has expanded its leadership team with four new members to help bolster the institute’s research resources, international relations, biostatistics efforts and data infrastructure.
On Nov. 8, Marco Salemi, Ph.D., will leave his role as associate director of research initiatives to serve as interim director of the University of Florida Emerging Pathogens Institute.
Glenn Morris, Jr., steps down from his role as director of the University of Florida’s Emerging Pathogens Institute, a globally recognized powerhouse for infectious disease research.
Global collaborations remain a recurring theme at EPI Research Day 2024, emphasizing their impact in driving breakthroughs in infectious diseases.
EPI investigator Song Liang enjoys introducing undergraduate students to the mesmerizing world of pathogens research. His most recent mentee, Lindsay Richards, recently won UF’s campus-wide Undergraduate Research Symposium best paper competition in the STEM/Medicine category.
The nation's crippled vaccination program has led to record numbers in cases of measles, diphtheria and other vaccine-preventable diseases, creating a regional public health crisis.
In 2016, Florida was second only to California for the number of new HIV diagnoses, and it consistently ranks among the top three states for its rate of new infections. The Miami metro area in particular has the highest HIV infection rate in the country, and Jacksonville is also counted among the top ten cities in the United States for its HIV infection rate.
A virus first found in Tampa Bay-area mosquitoes that appears to cause a rash and mild fever has been identified in humans for the first time, according to University of Florida researchers.
The Global Health Innovative Technology Fund has awarded $3.2 million to UF, and partners in the U.S. and Japan, to advance a promising vaccine for malaria transmission prevention.